Data

A Phase II Study of Ibrutinib, Rituximab and mini-CHOP therapy in very elderly patients with newly diagnosed DLBCL (NHL29)

Health Data Australia Contributor Records
Trotman, Judith ; Australasian Leukaemia And Lymphoma Group (ALLG) ; Australasian Leukaemia And Lymphoma Group (ALLG)
Viewed: [[ro.stat.viewed]] Cited: [[ro.stat.cited]] Accessed: [[ro.stat.accessed]]
ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Adc&rfr_id=info%3Asid%2FANDS&rft_id=info:doi10.58109/3XDT-2V79&rft.title=A Phase II Study of Ibrutinib, Rituximab and mini-CHOP therapy in very elderly patients with newly diagnosed DLBCL (NHL29)&rft.identifier=http://doi.org/10.58109/3XDT-2V79&rft.publisher=Australasian Leukaemia and Lymphoma Group (ALLG)&rft.description=Dataset includes: Data for 80 patients aged >75 years Treatment of Elderly patient cohort with newly diagnosed Diffuse large B cell lymphoma (DLBCL) with Ibrutinib, Rituximab and mini-CHOP therapy Demographic data, diagnostic data, treatment data, outcome data&rft.creator=Trotman, Judith &rft.creator=Australasian Leukaemia And Lymphoma Group (ALLG) &rft.creator=Australasian Leukaemia And Lymphoma Group (ALLG) &rft.date=2023&rft.relation=https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=ACTRN12615000551594&rft_subject=Chemotherapy&rft.type=dataset&rft.language=English Access the data

Full description

Dataset includes: Data for 80 patients aged >75 years Treatment of Elderly patient cohort with newly diagnosed Diffuse large B cell lymphoma (DLBCL) with Ibrutinib, Rituximab and mini-CHOP therapy Demographic data, diagnostic data, treatment data, outcome data

Notes

HeSANDA 1.0.0

Issued: 2023

This dataset is part of a larger collection

Click to explore relationships graph
Subjects

User Contributed Tags    

Login to tag this record with meaningful keywords to make it easier to discover

Other Information
Efficacy of Ibrutinib, Rituximab and Mini-CHOP in Very Elderly Patients with Newly Diagnosed Diffuse Large B Cell Lymphoma: Primary Analysis of the Australasian Leukaemia & Lymphoma Group NHL29 Study

doi : https://doi.org/10.1182/blood-2021-149019

The Genetic Landscape in Elderly DLBCL Aged > 75 Years in the Australasian Leukaemia & Lymphoma Group NHL29 Iric Trial Identifies New Targetable Mutations

doi : https://doi.org/10.1182/blood-2020-141795

Australasian Leukaemia And Lymphoma Group (ALLG)

ROR : https://ror.org/05t72y326

Australasian Leukaemia and Lymphoma Group (ALLG)

ROR : https://ror.org/05t72y326

Identifiers